Sort   by:  
 Page size 
UnknownTumor fraction in cell-free DNA as a biomarker in prostate cancer.
Not available
S-EPMC6238737 | biostudies-literature
UnknownEfficacy of Pirtobrutinib Monotherapy in Treatment-Naive Chronic Lymphocytic Leukemia: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Not available
S-EPMC12939900 | biostudies-literature
UnknownEverolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
Not available
S-EPMC6173710 | biostudies-literature
UnknownEvaluation of ERK as a therapeutic target in acute myelogenous leukemia.
Not available
S-EPMC7852028 | biostudies-literature
UnknownCirculating Cell-Free DNA as Biomarker of Taxane Resistance in Metastatic Castration-Resistant Prostate Cancer.
Not available
S-EPMC8391478 | biostudies-literature
UnknownAbemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study.
Not available
S-EPMC8551846 | biostudies-literature
UnknownExemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial.
Not available
S-EPMC10951222 | biostudies-literature
UnknownAbemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study.
Not available
S-EPMC9637121 | biostudies-literature
UnknownImpact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study.
Not available
S-EPMC11053007 | biostudies-literature
UnknownStructural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.
Not available
S-EPMC3914206 | biostudies-literature
Sort   by:  
 Page size